{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1178.71",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2022-07-16T01:02:12.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "AHA Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-02-03"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2022-07-16"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.71",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1178.71"
    }
  ],
  "version" : "20220716",
  "name" : "IntoleranceToMRATherapy",
  "title" : "Intolerance to MRA Therapy",
  "status" : "active",
  "experimental" : false,
  "date" : "2022-07-16T01:02:12-04:00",
  "publisher" : "AHA Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of diagnoses of intolerance to mineralocorticoid receptor antagonist (MRA) ingredients.),(Data Element Scope: This value set may use a model element related to Diagnosis.),(Inclusion Criteria: Includes concepts that represent a diagnosis of intolerance to MRA Therapy.),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://snomed.info/sct",
        "concept" : [
          {
            "code" : "293472002",
            "display" : "Spironolactone adverse reaction (disorder)"
          },
          {
            "code" : "470681000124105",
            "display" : "Adverse reaction caused by eplerenone (disorder)"
          },
          {
            "code" : "471491000124103",
            "display" : "Eplerenone not tolerated (situation)"
          },
          {
            "code" : "471941000124100",
            "display" : "Spironolactone not tolerated (situation)"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:4fed094a-14a7-4eb2-a857-18945ed77b96",
    "timestamp" : "2023-11-26T17:27:44-05:00",
    "total" : 4,
    "contains" : [
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20230901",
        "code" : "293472002",
        "display" : "Spironolactone adverse reaction (disorder)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20230901",
        "code" : "470681000124105",
        "display" : "Adverse reaction caused by eplerenone (disorder)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20230901",
        "code" : "471491000124103",
        "display" : "Eplerenone not tolerated (situation)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20230901",
        "code" : "471941000124100",
        "display" : "Spironolactone not tolerated (situation)"
      }
    ]
  }
}
